TIRZEPATIDE (GLP-1/GIP)
Feel Better. Eat Less. Live Healthier.
$250/month

 

Tirzepatide is a once-weekly injectable medication that helps support sustainable weight loss by targeting two naturally occurring hormones involved in appetite regulation and blood sugar control: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
 

By working with your body’s natural metabolic pathways, tirzepatide can help you:
 

• Reduce appetite and cravings

• Feel full sooner and stay satisfied longer

• Support healthy blood sugar regulation

• Improve insulin sensitivity

• Promote steady, sustainable weight loss

• Help reduce visceral (abdominal) fat

• Support long-term metabolic health
   

Many patients notice they naturally eat smaller portions, experience fewer cravings for sweets and alcohol, and have better control over emotional eating.
 

Who May Benefit?
 

Tirzepatide may be appropriate for adults who:

• Have overweight or obesity

• Have weight-related medical conditions

• Have struggled with traditional diet and exercise alone

• Want a physician-supervised medical weight-loss program
   

What to Expect
 

Treatment begins with a low dose that is gradually increased based on your response and tolerance. Our program includes a comprehensive medical evaluation, individualized treatment plan, ongoing monitoring, and lifestyle coaching to help you achieve long-term success.
 

Healthy nutrition, adequate protein intake, regular physical activity, hydration, and strength training remain essential components of every successful weight-loss program.

 

RETATRUTIDE (Triple Hormone Therapy)*

The Next Generation of Medical Weight Management
$250/month
 

Retatrutide is an investigational once-weekly injectable medication designed to support significant weight loss and metabolic health by activating three hormone receptors involved in appetite regulation and energy balance:
 

GLP-1 – Helps reduce appetite and slow stomach emptying.

GLP – Supports insulin sensitivity and metabolic function.

Glucagon – Increases energy expenditure and promotes fat utilization.
 

This triple-agonist approach is designed to address weight management through multiple complementary mechanisms.
 

Potential benefits may include:
 

• Significant weight reduction

• Reduced hunger and food cravings

• Improved feelings of fullness

• Increased calorie expenditure

• Reduction in visceral fat

• Improved insulin sensitivity and metabolic health

• Better long-term weight management when combined with healthy lifestyle habits
  
   

YOUR WEIGHT LOSS PROGRAM INCLUDES:
 

• Medication

• Weekly one-on-one check-ins with your registered nurse

• All supplies delivered to you

• Ongoing medical oversight and dose management
   

Every treatment plan begins with a comprehensive medical consultation, review of your health history, and individualized dosing strategy. Regular follow-up appointments allow us to monitor your progress, manage side effects, and adjust treatment as needed.

 

Important Information
 

Retatrutide is currently an investigational medication and has not been approved by the U.S. Food and Drug Administration (FDA) for commercial use. It should only be considered after a thorough discussion of its potential benefits, risks, and investigational status with your healthcare provider.
 

Successful long-term weight management also depends on balanced nutrition, adequate protein intake, regular exercise, hydration, quality sleep, and ongoing lifestyle support.

 

Important Safety Information for both Trizipetide and Retatrutide
 

Possible Side Effects
The most common side effects are generally mild to moderate and often improve as your body adjusts to treatment. They may include:
 

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Stomach pain or bloating

• Indigestion or heartburn

• Decreased appetite

• Fatigue

• Headache

• Dizziness

• Injection site redness or irritation
   

Less common but serious side effects may include:
 

• Pancreatitis (inflammation of the pancreas)

• Gallbladder disease, including gallstones

• Dehydration

• Acute kidney injury (often related to severe dehydration)

• Severe allergic reactions
   

Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, jaundice (yellowing of the skin or eyes), difficulty breathing, or swelling of the face, lips, tongue, or throat.
 

Contraindications
 

GLP-1 medications may not be appropriate if you:

• Are pregnant or breastfeeding

• Have a personal or family history of Medullary Thyroid Carcinoma (MTC)

• Have Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2)

• Have a history of pancreatitis (requires careful evaluation)

• Have severe gastroparesis or significant gastrointestinal motility disorders

• Have a known allergy to tirzepatide or any of its ingredients
   

Tell your provider if you have kidney disease, liver disease, gallbladder disease, diabetic retinopathy, diabetes requiring insulin or sulfonylureas, or are taking other prescription medications.
 

Medical Disclaimer
 

All patients must complete a medical consultation and health screening before treatment. Medication is prescribed only when deemed medically appropriate by a licensed healthcare provider. Individual results vary and no specific amount of weight loss can be guaranteed.